Please read and agree to the terms and conditions of this site.
@bgr.com 1 year ago
Trial begins for radioactive gel that painlessly kills skin cancer in seconds
@venturebeat.com 6 years ago
Augmenix Partners with Us TOO International to Stream Live Webcast and Q & A on Prostate Cancer Radiation Therapy
@venturebeat.com 6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@venturebeat.com 7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com 7 years ago
Seven Bridges to Present on Cancer Moonshot’s Blood Profiling Atlas at Precision Medicine World Congress
@dataelixir 7 years ago
Cancer Research Orgs Release Big Data for Precision Medicine via Health IT Analytics http://datalxr.com/2jsdt4S #BigData #PrecisionMedicine
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@techcrunch.com 7 years ago
Grail is raising at least $1 billion to fund its early cancer screening test
@venturebeat.com 7 years ago
National Cancer Institute Extends Scope of Seven Bridges Cancer Genomics Cloud Pilot